Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non‐Small Cell Lung Carcinoma

Concomitant administration of bevacizumab and pemetrexed‐cisplatin is a common treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Vascular normalization following bevacizumab administration may transiently enhance drug delivery, suggesting improved efficacy with sequential admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Imbs, Diane‐Charlotte, El Cheikh, Raouf, Boyer, Arnaud, Ciccolini, Joseph, Mascaux, Céline, Lacarelle, Bruno, Barlesi, Fabrice, Barbolosi, Dominique, Benzekry, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784740/
https://www.ncbi.nlm.nih.gov/pubmed/29218795
http://dx.doi.org/10.1002/psp4.12265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784740/
https://www.ncbi.nlm.nih.gov/pubmed/29218795
http://dx.doi.org/10.1002/psp4.12265

Ejemplares similares